Chase A. Pagani

Chase A. Pagani

Auto-generated profile, based on publicly available information

Chase A. Pagani

Department of Surgery, University of Texas Southwestern Medical Center, Dallas, United States of America

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSMichael Sorkin
Michael Sorkin
AHAmanda K. Huber
Amanda K. Huber
CHCharles Hwang
Charles Hwang
WCWilliam F. Carson
William F. Carson
RMRajasree Menon
Rajasree Menon
BLBenjamin Levi
Benjamin Levi
Heterotopic ossification (HO) is an aberrant regenerative process with ectopic bone induction in response to musculoskeletal trauma, in which mesenchymal stem cells (MSC) differentiate into osteochondrogenic cells instead of myocytes or tenocytes. Despite frequent cases of hospitalized musculoskeletal trauma, the inflammatory responses and cell population dynamics that regulate subsequent wound healing and tissue regeneration are still unclear. Here we examine, using a mouse model of trauma-induced HO, the local microenvironment of the initial post-injury inflammatory response. Single cell transcriptome analyses identify distinct monocyte/macrophage populations at the injury site, with their dynamic changes over time elucidated using trajectory analyses. Mechanistically, transforming growth factor beta-1 (TGFβ1)-producing monocytes/macrophages are associated with HO and aberrant chondrogenic progenitor cell differentiation, while CD47-activating peptides that reduce systemic macrophage TGFβ levels and help ameliorate HO. Our data thus implicate CD47 activation as a therapeutic approach for modulating monocyte/macrophage phenotypes, MSC differentiation and HO formation during wound healing.

16 June 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
CHCharles D. Hwang
Charles D. Hwang
CPChase A. Pagani
Chase A. Pagani
JNJohanna H Nunez
Johanna H Nunez
MCMasnsen Cherief
Masnsen Cherief
QQQizhi Qin
Qizhi Qin
BLBenjamin Levi
Benjamin Levi
Heterotopic ossification (HO) is the formation of ectopic bone that is primarily genetically driven (fibrodysplasia ossificans progressiva [FOP]) or acquired in the setting of trauma (tHO). HO has undergone intense investigation, especially over the last 50 years, as awareness has increased around improving clinical technologies and incidence, such as with ongoing wartime conflicts. Current treatments for tHO and FOP remain prophylactic and include NSAIDs and glucocorticoids, respectively, whereas other proposed therapeutic modalities exhibit prohibitive risk profiles. Contemporary studies have elucidated mechanisms behind tHO and FOP and have described new distinct niches independent of inflammation that regulate ectopic bone formation. These investigations have propagated a paradigm shift in the approach to treatment and management of a historically difficult surgical problem, with ongoing clinical trials and promising new targets.

1 October 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
AHAmanda K. Huber
Amanda K. Huber
NPNicole Patel
Nicole Patel
CPChase A. Pagani
Chase A. Pagani
SMSimone Marini
Simone Marini
KPKarthik R. Padmanabhan
Karthik R. Padmanabhan
BLBenjamin Levi
Benjamin Levi
Cells sense the extracellular environment and mechanical stimuli and translate these signals into intracellular responses through mechanotransduction, which alters cell maintenance, proliferation, and differentiation. Here we use a mouse model of trauma-induced heterotopic ossification (HO) to examine how cell-extrinsic forces impact mesenchymal progenitor cell (MPC) fate. After injury, single-cell (sc) RNA sequencing of the injury site reveals an early increase in MPC genes associated with pathways of cell adhesion and ECM-receptor interactions, and MPC trajectories to cartilage and bone. Immunostaining uncovers active mechanotransduction after injury with increased focal adhesion kinase signaling and nuclear translocation of transcriptional coactivator TAZ, inhibition of which mitigates HO. Similarly, joint immobilization decreases mechanotransductive signaling, and completely inhibits HO. Joint immobilization decreases collagen alignment and increases adipogenesis. Further, scRNA sequencing of the HO site after injury with or without immobilization identifies gene signatures in mobile MPCs correlating with osteogenesis, and signatures from immobile MPCs with adipogenesis. scATAC-seq in these same MPCs confirm that in mobile MPCs, chromatin regions around osteogenic genes are open, whereas in immobile MPCs, regions around adipogenic genes are open. Together these data suggest that joint immobilization after injury results in decreased ECM alignment, altered MPC mechanotransduction, and changes in genomic architecture favoring adipogenesis over osteogenesis, resulting in decreased formation of HO.

15 April 2020 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
DSDavid M. Stepien
David M. Stepien
CHCharles Hwang
Charles Hwang
SMSimone Marini
Simone Marini
CPChase A Pagani
Chase A Pagani
MSMichael Sorkin
Michael Sorkin
BLBenjamin Levi
Benjamin Levi
Myeloid cells are critical to the development of fibrosis following muscle injury; however, the mechanism of their role in fibrosis formation remains unclear. In this study, we demonstrate that myeloid cell–derived TGF-β1 signaling is increased in a profibrotic ischemia reperfusion and cardiotoxin muscle injury model. We found that myeloid-specific deletion of Tgfb1 abrogates the fibrotic response in this injury model and reduces fibro/adipogenic progenitor cell proliferation while simultaneously enhancing muscle regeneration, which is abrogated by adaptive transfer of normal macrophages. Similarly, a murine TGFBRII-Fc ligand trap administered after injury significantly reduced muscle fibrosis and improved muscle regeneration. This study ultimately demonstrates that infiltrating myeloid cell TGF-β1 is responsible for the development of traumatic muscle fibrosis, and its blockade offers a promising therapeutic target for preventing muscle fibrosis after ischemic injury. Key Points IRCTX muscle injury results in muscle fibrosis through macrophage-derived TGF-β1. FAPs respond to TGF-β1 by differentiating into fibroblasts. Conditional knockout and systemic inhibition of TGF-β1 attenuates IRCTX fibrosis. Visual Abstract

24 October 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
NPNicole K. Patel
Nicole K. Patel
JNJohanna H Nunez
Johanna H Nunez
MSMichael Sorkin
Michael Sorkin
SMSimone Marini
Simone Marini
CPChase A. Pagani
Chase A. Pagani
BLBenjamin Levi
Benjamin Levi
Transforming growth factor–β1 (TGF-β1) plays a central role in normal and aberrant wound healing, but the precise mechanism in the local environment remains elusive. Here, using a mouse model of aberrant wound healing resulting in heterotopic ossification (HO) after traumatic injury, we find autocrine TGF-β1 signaling in macrophages, and not mesenchymal stem/progenitor cells, is critical in HO formation. In-depth single-cell transcriptomic and epigenomic analyses in combination with immunostaining of cells from the injury site demonstrated increased TGF-β1 signaling in early infiltrating macrophages, with open chromatin regions in TGF-β1–stimulated genes at binding sites specific for transcription factors of activated TGF-β1 (SMAD2/3). Genetic deletion of TGF-β1 receptor type 1 ( Tgfbr1 ; Alk5 ), in macrophages, resulted in increased HO, with a trend toward decreased tendinous HO. To bypass the effect seen by altering the receptor, we administered a systemic treatment with TGF-β1/3 ligand trap TGF-βRII-Fc, which resulted in decreased HO formation and a delay in macrophage infiltration to the injury site. Overall, our data support the role of the TGF-β1/ALK5 signaling pathway in HO.

10 December 2019 in Bone Research
Verified
Journal Article
Open access
PDF file
CHCharles Hwang
Charles Hwang
SMSimone Marini
Simone Marini
AHAmanda K. Huber
Amanda K. Huber
DSDavid M. Stepien
David M. Stepien
MSMichael Sorkin
Michael Sorkin
BLBenjamin Levi
Benjamin Levi
Heterotopic ossification (HO) is a debilitating condition characterized by the pathologic formation of ectopic bone. HO occurs commonly following orthopedic surgeries, burns, and neurologic injuries. While surgical excision may provide palliation, the procedure is often burdened with significant intra-operative blood loss due to a more robust contribution of blood supply to the pathologic bone than to native bone. Based on these clinical observations, we set out to examine the role of vascular signaling in HO. Vascular endothelial growth factor A (VEGFA) has previously been shown to be a crucial pro-angiogenic and pro-osteogenic cue during normal bone development and homeostasis. Our findings, using a validated mouse model of HO, demonstrate that HO lesions are highly vascular, and that VEGFA is critical to ectopic bone formation, despite lacking a contribution of endothelial cells within the developing anlagen.